Two-Year Health Care Costs For Weight Loss Surgery Lower Than GLP-1 Drugs

Over two years, costs for people with obesity a body mass index of 35 or higher) and type 2 diabetes who underwent metabolic and bariatric surgery (MBS) were lower than costs for those who were prescribed a glucagon-like peptide-1 receptor agonists (GLP-1RAs) for weight loss over two years. A recent study compared cost outcomes for GLP-1 medications over two years to costs for matched groups that underwent MBS as either sleeve gastrectomy or gastric bypass.

The researchers analyzed data from the STATinMED RWD Insights all-payer claims database to identify 90,769 people between 2017 and . . .